Press-release for stocks related to for

| 763.37% | O: 23.56% H: 100.32% C: 11.06%
company life acquire for smart agreement

Smart for Life Releases Corporate Video on Definitive Agreement to Acquire Purely Optimal Nutrition
Published: 2024-04-08 (Crawled : 17:00) - globenewswire.com
SMFL | $4.32 -7.69% -8.33% 680K

| 763.37% | O: 23.56% H: 100.32% C: 11.06%
nutrition life acquire for smart agreement

Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JAGX | News | $0.1704 1.43% 1.41% 34M

| 43.1% | O: 26.26% H: 73.2% C: 18.87%
health cancer care for commercial

Blue Star Foods Signs Agreement with Eagle Rising to Provide High-Quality, Nutritious Meals for U.S. Military
Published: 2024-04-10 (Crawled : 15:00) - globenewswire.com
BSFC | $0.0658 -0.3% -0.3% 3.8M

| -30.0% | O: 0.0% H: 60.0% C: -10.0%
foods for star blue military agreement

Rodedawg Ind. Intl., Inc. Announces New Officers Appointment for Elixicure, LLC
Published: 2024-04-23 (Crawled : 13:30) - globenewswire.com
RWGI | $0.025 66.67% 180K

n/a

| 0.0% | O: -33.33% H: 50.0% C: 50.0%
for

Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
LGVN | $1.73 -4.95% -5.2% 300K

| 1.78% | O: 41.42% H: 42.68% C: 22.59%
conference disease association alzheimer’s presentation international research for trial

Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
BNTC | $6.75 -1.6% -1.63% 66K

| 34.67% | O: 5.41% H: 41.06% C: 29.66%
bb-301 first positive biopharma for trial opmd study

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
SNGX | $0.385 -3.75% -3.9% 490K

| -1.58% | O: 75.34% H: 37.73% C: -30.58%
fda drug marburg infection designation for grants

Department of Justice to Publish Final Rule for Digital Accessibility, Advancing the ADA's Commitment to Equal Rights for All
Published: 2024-04-09 (Crawled : 13:00) - prnewswire.com
AEYE | $14.43 7.05% 6.58% 480K

| 60.16% | O: 5.55% H: 35.02% C: 26.92%
for

Beamr to enable real-time video streaming over 5G with NVIDIA Holoscan for Media
Published: 2024-04-09 (Crawled : 16:00) - globenewswire.com
BMR | $5.63 0.36% 0.36% 320K

n/a

| -8.71% | O: -0.97% H: 34.57% C: 22.15%
media for nvidia

Rising Demand for Encryption Technology Fuels Investments in Leading Solution Providers
Published: 2024-04-23 (Crawled : 13:30) - globenewswire.com
EBZT | $0.5606 -24.29% 24K

n/a

| 40.0% | O: 7.5% H: 30.23% C: 30.23%
investments solution for technology

PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions
Published: 2024-04-09 (Crawled : 13:00) - globenewswire.com
PRFX | $0.841 -5.48% -5.8% 23K

| -49.41% | O: 15.88% H: 29.44% C: -23.35%
treatment for

PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
PXMD | $0.7003 -2.19% -2.24% 250K

| 4.55% | O: 4.55% H: 28.99% C: 15.94%
health for

Uncle Bud’s Health and Wellness to Expand New Premium Collection with Novel Products for Sleep, Memory, Pain, Immunity, Feminine Hygiene, and Sexual Wellness
Published: 2024-04-11 (Crawled : 15:00) - globenewswire.com
PBIO | $0.245 88.01% 5.2K

| 4.55% | O: 9.05% H: 25.05% C: 22.93%
health wellness for

Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
Published: 2024-04-11 (Crawled : 13:00) - globenewswire.com
CADL | $6.03 2.03% 1.99% 670K

| 18.63% | O: 25.49% H: 23.75% C: 13.75%
can-2409 fda drug cancer pancreatic treatment designation for therapeutics

Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
SYRS | $5.055 -1.65% -1.68% 90K

Mining, Quarrying, and Oil and ...

| 9.27% | O: 2.16% H: 23.21% C: 16.03%
fda treatment designation for aml

Eco Wave Power Signed a Contract with a Major Energy Company for a Demonstration to Harness Energy from the Waves at the Port of Los Angeles
Published: 2024-04-11 (Crawled : 13:00) - ecowavepower.com
WAVE | $3.41 -3.13% -3.23% 100K

| -7.1% | O: 0.0% H: 22.95% C: -1.64%
angeles energy company contract for

Perpetua Resources Receives Indication for up to $1.8 Billion Financing from Export-Import Bank of the United States for Stibnite Gold Project
Published: 2024-04-08 (Crawled : 11:00) - prnewswire.com
PPTA 4 | $5.93 -5.2% -5.48% 300K

| 31.87% | O: 12.37% H: 20.71% C: 17.35%
for

Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity
Published: 2024-04-18 (Crawled : 11:00) - biospace.com/
BPTS | $10.15 3.36% 3.25% 3.7K

| 3244.83% | O: 0.0% H: 20.69% C: 10.34%
obesity for study

← Previous
1
2
3
4
5
6
7
8
9
…
46
47
Next →

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M

Consumer Services

BOF | $1.99 70.09% 41.21% 110M

ILAG | $0.51 6.03% 40.62% 1.7M

LICN | $0.941 68.04% 40.49% 15M

AMST | $3.31 65.5% 39.58% 70M

MTC | $3.615 61.38% 38.04% 9.3M

WIMI | $1.15 58.53% 36.92% 19M